MedPath

The Australian Ultraviolet Radiation and Immunity Study

Not Applicable
Completed
Conditions
Impact of solar ultraviolet radiation on human primary immune response to immunisation with a T-cell dependent antigen (Keyhole Limpet Hemocyanin or KLH)
Inflammatory and Immune System - Normal development and function of the immune system
Registration Number
ACTRN12610000234011
Lead Sponsor
Dr Robyn Lucas
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
210
Inclusion Criteria

* Age 18 - 40 years
* Healthy
* Willing and able to sign informed consent

Exclusion Criteria

* Allergy to shellfish
* Pregnancy or breastfeeding
* Previous KLH vaccination
* Immunosuppressive medications
* Immunosuppressive medical condition
* Recent infection (within 2 weeks of vaccination)
* Recent immunisation with any other vaccine in past 4 weeks
* Photosensitive skin or taking photosensitsing medication

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Humoral response to primary subcutaneous vaccination with Keyhole Limpet Hemocyanin (KLH). KLH-specific immunoglobulins (Ig) (Ig types M, E, G and subsets) will be quantified via enzyme linked immunoassay techniques.[KLH specific antibody titres taken at baseline (immediately prior to vaccination which follows the 5 days of UVR exposure measurement); 1 week and 3 weeks post vaccination]
Secondary Outcome Measures
NameTimeMethod
Delayed-type hypersensitivity (DTH) response to intra-dermal KLH will be measured in millimetres of skin reaction[Intradermal KLH given at day 21 post vaccination. DTH response read at 48 hours post intradermal KLH.];KLH specific T-cell response will be measured via lymphocyte proliferation assays and cytokine production.[Measured at baseline (immediately prior to vaccination) and day 21.]
© Copyright 2025. All Rights Reserved by MedPath